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Background: 5-Aminolevulinic acid (ALA) and its derivatives have been widely used in 
photodynamic therapy. The main drawback associated with ALA-based photodynamic therapy 
(ALA-PDT) and ALA fluorescence diagnosis results from the hydrophilic nature of ALA and 
lack of selectivity for tumor versus nontumor cells. The application of certain triggers, such 
as pH, into conventional sensitizers for controllable  1O2 release is a promising strategy for 
tumor-targeted treatment.
Methods: A series of pH-sensitive ALA-poly(L-histidine) [p(L-His)n] prodrugs were 
synthesized via ring opening polymerization of 1-benzyl-N-carboxy-L-histidine anhydride 
initiated by the amine hydrochloride group of ALA itself. As an alternative to ALA for PDT, 
the synthesized prodrugs were used to treat a cultured human colon cancer HCT116 cell line 
under different pH conditions. The effect of ALA-p(L-His)n derivatives was evaluated by 
monitoring the fluorescence intensity of protoporphyrin IX, and measuring the cell survival 
rate after suitable light irradiation.
Results: The cytotoxicity and dark toxicity of ALA and synthesized ALA-p(L-His) derivatives in 
HEK293T and HCT116 cells in the absence of light at pH 7.4 and 6.8 shows that the cell viability 
was relatively higher than 100%. ALA-p(L-His)n showed high phototoxicity and selectivity in 
different pH conditions compared with ALA alone. Because the length of the histidine chain 
increases in the ALA-p(L-His)n prodrugs, the PDT effect was found to be more powerful. In 
particular, high phototoxicity was observed when the cells were treated with ALA-p(L-His)15, 
compared with treatment using ALA alone.
Conclusion: The newly synthesized ALA-p(L-His)n derivatives are an effective alternative to 
ALA for enhancing protoporphyrin IX production and the selectivity of the phototoxic effect 
in tumor cells.
Keywords: 5-aminolevulinic acid, photodynamic therapy, poly(L-histidine), bioconjugate, 
cancer cells
Introduction
Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) is gaining increasing 
attention in medicine as an important and effective technique for the treatment of a vari-
ety of neoplastic lesions and premalignant disorders.1 In recent years, fluorescent photo-
detection has received increasing attention as a new approach for the selective detection 
and treatment of cancer. One major mechanism is the production of the photosensitizer, 
protoporphyrin IX (PpIX), from the precursor, ALA. The external addition of ALA or 
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its derivatives results in enhanced synthesis of porphyrin by 
cells. James and Pottier first described an in situ approach to 
the conversion of ALA, a nonphotoactivable precursor, into 
PpIX, a naturally occurring photosensitizing species, via the 
cellular heme biosynthetic pathway.2 In clinical application, 
when sufficient intracellular levels of PpIX are generated, 
the targeted tissue is irradiated by a light of suitable wave-
length to activate the sensitizer and trigger a chain of events 
that ultimately result in cell death. At the molecular level, 
this involves interaction of the excited photosensitizer with 
molecular oxygen, leading to generation of electrophilic 
species (singlet oxygen and/or radicals) that cause oxida-
tive damage to cellular constituents, such as phospholipid 
membranes, nucleic acids, and proteins.3
PpIX generated by exogenous ALA administration has 
several advantages over other types of photosensitizers, 
such as synthetic porphyrin or phthalocyanine derivatives 
that have been applied in PDT. For example, the risk of 
overtreatment with ALA-PDT is limited because of the fast 
clearance of ALA from the body, while the saturation of PpIX 
production at high ALA doses also prevents excessive PpIX 
production in tissues.4 The relatively rapid photobleaching 
of PpIX also means that the phototoxic effects of ALA-PDT 
are not persistent.5 The main drawback associated with 
ALA-PDT and ALA fluorescence diagnosis results from 
the hydrophilic nature of ALA itself. At physiological pH, 
ALA is a zwitter ion; this retards its ability to cross through 
biological barriers such as cellular membranes, resulting in 
nonhomogeneous distribution in the targeted tissue.5 The 
selectivity of PDT is an important factor because normal 
cells are also able to accumulate sensitizers, which leads to 
prolonged skin photosensitization. Thus, an improvement in 
the selectivity of photosensitizers for tumor versus nontumor 
cells is needed.
To overcome this difficulty, several chemical approaches 
have been attempted to improve the incorporation and 
selectivity of ALA. One approach has been to use more 
lipophilic ALA derivatives, such as alkyl or ethylene glycol 
esters, which are potential substrates for cellular esterases,6–9 
or different delivery systems, including dendrimers10–12 
and liposomes.13,14 The use of alkyl esters of ALA results 
in nonspecific distribution of ALA in all cell types, but 
with increased PpIX production in tumor cells.15 Another 
approach to obtaining ALA prodrugs that have both improved 
physiochemical properties and can selectively release ALA 
in specific cell lines is to incorporate ALA into short peptide 
derivatives. These are stable at physiological pH, unlike ALA 
and its esters. In this regard, Casas et al16 and Berger et al17 
have shown that incorporation of ALA into a short peptide 
derivative would provide a suitable means of facilitating both 
transdermal delivery and improved selectivity for cancerous 
cells, presenting potential substrates for cell surface and 
cytoplasmic peptidases and/or ligands for peptide and amino 
acid transporters. Following this approach, Ludovic et al18 and 
Giuntini et al19 also showed that the incorporation of ALA 
into short peptide derivatives is an effective general approach 
for increasing cellular delivery of ALA.
The application of certain features, such as pH or bio-
affinity, into conventional sensitizers for controllable  1O2 
release has been the subject of great interest. The selectivity 
of a sensitizer that produces 1O2 at acidic pH, but is almost 
deactivated at physiological pH, would be beneficial in cancer 
treatment because the pH in growing malignant tumors tends 
to be somewhat lower than that in surrounding normal tissue. 
Very recently, Zhu et al20 showed that imidazole-modified 
porphyrin is a pH-responsive sensitizer for photodynamic 
cancer therapy.
In order to enter cellular porphyrin biosynthetic pathways, 
precursor photosensitizers must be effectively internalized by 
target cells and processed into the photosensitizer, PpIX. In 
this general context, we investigated the use of novel short 
polypeptide-tagged ALA prodrugs to improve the uptake 
and cell selectivity of ALA. Poly(L-histidine) [p(L-His)] 
was selected because of its interesting properties; it is known 
to show endosomal membrane disruption activity, which is 
induced by the “proton sponge” mechanism of imidazole 
groups.21,22 The objective of the present study was to 
formulate PpIX from p(L-His)-tagged 5-ALA derivatives and 
to measure the resulting uptake, intracellular distribution, and 
effectiveness in PDT against human colon cancer (HCT116) 
cells under varying pH conditions. ALAs containing various 
lengths of p(L-His) chains were synthesized, and their PpIX 
generation and efficiency were investigated.
Materials and methods
ALA, 3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyltetrazolium 
bromide (MTT), and propidium iodide were purchased 
from Sigma Chemical Company (St Louis, MO). FITC-
annexin V was obtained from Santa Cruz Biotechnology 
(Santa Cruz, CA). N, N′-dimethylformamide (DMF) 
was distilled over sodium. 1, 4-Dioxane was purified by 
column chromatography on activated Al2O3 to remove 
peroxide impurities and then distilled. All other reagent 
grade chemicals such as N-α-t-butyloxycarbonyl-N-
im-benzyl-l-histidine (Boc-L-His (Bn)-OH) and PCl5, were 
purchased from Sigma and used without further purification. 
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Cell culture materials were purchased from Invitrogen (Grand 
Island, NY).
Synthesis of 1-benzyl-N-carboxy- 
L-histidine anhydride
Boc-His(Bn)-OH 2.5 g was suspended in anhydrous 
1,4-dioxane (10 mL), to which a solution of phosphorus 
  pentachloride (1.8 g) in 1,4-dioxane (20 mL) was added to 
form N-carboxyanhydride (NCA) at 25°C under stirring. 
Within a few minutes, a clear solution was obtained and then 
filtered through a glass filter. Crystals of 1-benzyl-N-carboxy-
L-histidine anhydride were obtained after the addition of 
the filtrate to an excess of diethyl ether. The product was 
subsequently washed and dried under vacuum.
Synthesis of ALA-p(Bn-L-His)n
p(L-His)-tagged ALA derivatives were synthesized by ring 
opening polymerization of benzyl-N-carboxy-L-histidine 
anhydride utilizing the amino group of ALA as an initiator. 
Typically, ALA (0.0655 g, 0.5 mmoL) and benzyl-N-
carboxy-L-histidine anhydride monomer (1.35 g, 5 mmoL) 
were dissolved in DMF in two separate Schlenk flasks 
and subsequently combined using a transfer needle under 
nitrogen. The reaction mixture was stirred for three days 
at room temperature in a dark inert nitrogen atmosphere. 
After polymerization, the solvent was concentrated, and the 
DMF solution was precipitated in diethyl ether and dried 
under vacuum to yield ALA-p(Bn-L-His)n (n = 5, n = 10, 
or n = 15).
Deprotection of benzyl groups
A round-bottomed flask was charged with a solution of 
ALA-p(Bn-L-His)n in trifluoroacetic acid (200 mg, 3 mL). 
Then, a four-fold molar excess of a 33 w% solution of HBr in 
acetic acid was added, and the reaction mixture was stirred for 
2 hours at 0°C. Finally, the reaction mixture was precipitated 
in anhydrous diethyl ether, and the product was subsequently 
dried under vacuum to yield ALA-p(L-His)n as a yellow 
powder (n = 5, n = 10, or n = 15).
Characterization
1H nuclear magnetic resonance (NMR) spectra were recorded 
on a Varian Unity Plus-400 spectrometer. Ultraviolet-
visible spectroscopic analysis was performed on a Shimadzu 
UV-1650 PC, and Fourier-transform infrared spectra were 
recorded on a Shimadzu IR Prestige 21 spectrometer at room 
temperature. The spectra were taken in KBr discs in the range 
of 3500–500 cm−1.
The molecular weight and polydispersity index of the 
products were determined by gel permeation chromatography 
using two Styragel columns (HT3 and HT4, Waters 
  Company) at 40°C. DMF containing 0.1 N LiBr was used 
as a carrier solvent at a flow rate of 1.0 mL/minute. A Waters 
1515 pump and a Waters 2414 differential refractive index 
detector were used. Monodispersed polystyrene polymers 
were used as calibration standards.
Cell culture
Human embryonic kidney (HEK293T) cells and colorectal 
carcinoma (HCT116) cells were cultured in RPMI 
1640 medium (Gibco, Grand Island, NY) supplemented with 
10% fetal bovine serum (Invitrogen) and 1% antibiotics at 
37°C in 5% CO2. The cells were subcultured twice a week.
Cytotoxicity
HEK293T cells were seeded in 96-well plates at a density 
of 2 × 104 cells per well and incubated for 24 hours in 5% 
CO2 at 37°C. For the cytotoxicity test, the cells were then 
incubated in serum-free RPMI media for 24 hours. After 
removing the culture medium, the wells were washed with 
phosphate-buffered saline. Each well was then replaced with 
100 µL of fresh RPMI medium containing 0.1–1.0 mM ALA 
or ALA-p(L-His), and the cells were incubated in the dark 
at 37°C for 4 hours. After that, the cells were washed with 
phosphate-buffered saline three times and cytotoxicity was 
assessed using the MTT assay as described below.
Dark toxicity
HCT116 cells (2 × 104) were seeded into 96-well plates and 
treated with 1 mM of ALA or ALA-p(L-His), in serum-free 
medium for 4 hours. After that, the medium was changed 
to growth medium containing 10% fetal bovine serum 
without irradiation and incubated. After 24 hours, the cells 
were washed with phosphate-buffered saline twice and cell 
viability was measured by MTT assay.
Photodynamic treatment
HCT116 cells were seeded in 96-well plates, cultured for 
24 hours, and then washed with phosphate-buffered saline. 
Following this, 100 µL of serum-free medium containing 
1 mM ALA or ALA-p(L-His) was added to each well and 
the cells were incubated for 4 hours. Control wells were 
treated with serum-free medium in the absence of both 
ALA and ALA-p(L-His). The plates were then exposed 
to an expanded homogenous beam of 635 nm radiation at 
a dose of 1.0 J/cm2 as measured by the photoradiometer. 
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Immediately after irradiation, the medium was removed 
and the cells were washed with phosphate-buffered saline. 
Following this, 100 µL of fresh RPMI with 10% phosphate-
buffered saline was added, and the cells were incubated for 
a further 24 hours. Cell phototoxicity was determined by the 
MTT assay as described below.
MTT assay
The effect of PDT on cell proliferation was measured using 
a modified MTT assay. The MTT assay is based on the fact 
that live cells containing active mitochondria are able to 
cleave the tetrazolium ring to a molecule that absorbs light 
at 570 nm. Cells were cultured in 96-well plates at a density 
of 2 × 104. After removal of the culture medium, 100 µL of 
fresh medium containing 25 µL MTT reagent (2 mg/mL in 
phosphate-buffered saline, Sigma) was added to each well. 
The cells were further incubated at 37°C for 3 hours. The 
cells were then lysed with 100 µL of lysis buffer solution 
(10% sodium dodecyl sulfate in 0.01 N HCl) for 18 hours, 
and the absorbance was measured at 570 nm.
Fluorescence microscopy
PpIX products were observed using a fluorescence microscope. 
The microscope was equipped with a 460–480 nm excitation 
filter and a 610 nm emission filter for the detection of PpIX 
fluorescence. 1 × 106 HCT116 cells were seeded on a cover 
slip in each well of a 6-well plate. The cells were then treated 
with 1.0 mM ALA or ALA-p(L-His) for 4 hours in serum-
free media, after which the medium was discarded. The cells 
were then washed with phosphate-buffered saline, fixed 
with 4% paraformaldehyde in phosphate-buffered saline, 
mounted on a glass slide, and observed using a fluorescence 
microscope.
Flow cytometry analysis
To confirm cell death induced by PDT, at least 10,000 gated 
cells were studied using a FACScan flow cytometer   (Becton 
Dickinson Biosciences, San Jose, CA). Two reagents, FITC-
annexin V and propidium iodide, were used to identify 
apoptosis and necrosis of the HCT116 cells, respectively. 
The cells were treated with 1 mM of ALA or ALA-p(L-His) 
at pH 6.8 or 7.4 for 4 hours. After that, cells were irradiated 
at 635 nm with 1 J/cm2, and the cells collected were washed 
with phosphate-buffered saline. The control cell was not 
treated with any kind of drugs or light. The pellets were 
resuspended with binding buffer (10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid [HEPES] pH 7.4, 150 mM 
NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2) containing 
FITC-annexin V 1 µg/mL and incubated further for 
30 minutes. Ten minutes prior to termination of incubation, 
propidium iodide 10 µg/mL was added to stain necrotic 
cells under dark conditions. Following that, the cells were 
immediately analyzed using the FACScan flow cytometer.
Statistical data analysis
Results are expressed as the means of at least parallel 
experiments ± the standard deviation. Statistical data analysis 
was performed using the Student’s t-test, with P , 0.05 as 
the minimal level of significance.
Computational details
The density functional theory and Fukui indices calculations 
were performed using the DMol3 program implemented 
within the Materials Studio software version 4.3.1,23 a high 
quality quantum mechanics computer program (Accelrys, 
San Diego, CA). We optimized the geometry of ALA, ALA-
p(His)5, ALA-p(His)10, and ALA-p(His)15 in the aqueous 
phase. The aqueous phase was represented by the conductor-
like screening model (Cosmo).24,25 We calculated the energies 
and geometries of the compounds using the local density 
approximation of Vosko-Wilk-Nausair.26 The energies were 
then refined by single point energy calculations using the 
generalized gradient approximation (PW91) of Perdew and 
Wang.27 Computations for all models were performed using 
the double numerical plus polarization basis set.28
Results and discussion
Synthesis of ALA-p(L-His)
The initial step in ALA-induced synthesis of porphyrins is 
penetration of ALA through the plasma membrane. ALA 
is a hydrophilic molecule, and its hydrophilicity may be a 
clinical limitation for the use of ALA in PDT because of the 
low rate of hydrophilic drug uptake in cells and/or the poor 
penetration of such drugs through the tissue.29,30 Initially 
this problem was partly addressed by synthesis of lipophilic 
ester prodrugs that provide improved cellular uptake and are 
metabolized into PpIX following the action of nonspecific 
intracellular esterases. A more recent development concerns 
the preparation of peptide-based ALA prodrugs.16–19,31 This 
approach describes the synthesis and evaluation of short 
ALA peptide derivatives in which either the amino or the 
carboxyl function of the latter is masked, thereby providing 
improved physical properties and the potential for cell line-
specific ALA release.
Among these, poly(L-His) is found to be an excellent 
candidate because of its ability to confer tailored lipophilicity 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2500
Johnson et alInternational Journal of Nanomedicine 2012:7
and water solubility to the prodrugs. The physiologically 
relevant pH range is 5.0–7.4; prodrugs in which protona-
tion occurs within this pH range are suitable for fabricating 
pH-sensitive drugs for cellular level internalization. 
Importantly, the fusogenic activity of p(L-His) could disrupt 
the membrane envelope of acidic subcellular compartments 
such as endosomes, thus enhancing the delivery efficiency 
of the drug/nucleic acids to the cytosol.32
It is well known that a primary amine or amine hydro-
chloride group can initiate the polymerization of alpha amino 
acid N-carboxyanhydride.33 In this study, as an alternative 
approach, we utilized the amine hydrochloride functional-
ity of ALA for the synthesis of modified prodrugs. The 
synthesized pH-sensitive ALA-p(L-His) prodrugs are more 
lipophilic than ALA but are still water-soluble. The synthesis 
procedure for the prodrugs is shown in Figure 1.
The protective benzyl side chains were removed by 
treating ALA-p(Bn-His)n with HBr/AcOH in trifluoroa-
cetic acid, and the resulting product was characterized by 
gel permeation chromatography and various spectroscopic 
techniques. The  1H NMR spectra of ALA-p(L-His) are 
shown in Figure 2.
Gel permeation chromatography traces, as well as 
ultraviolet-visible and Fourier transform infrared spectra, 
are shown in the supplementary data (see Figures S1–S3). 
The molecular weight of ALA-p(L-His) as measured by gel 
permeation chromatography shows a slight overestimation 
of the molecular weight, even though the molecular weight 
calculated from 1H NMR agrees with the theoretical value. 
After deprotection, the peak integral ratio of the methylene 
proton of ALA (δ = 3.8 ppm) and (O=C−CH−) in the peptide 
block (δ = 4.95 ppm) was used to calculate Mn, confirming 
that there was no loss of the histidine repeating units during 
deprotection. Therefore, we can ascertain that polymerization 
of Bn-His-NCA and deprotection of the benzyl groups were 
successfully accomplished using ALA as the initiator.
Computational study
The reactivity of a compound is considered to be closely 
related to its frontier molecular orbitals, ie, the highest occu-
pied molecular orbital (HOMO) and the lowest unoccupied 
molecular orbital (LUMO). Higher HOMO energy (EHOMO) 
of the molecule means a higher electron-donating capability 
to appropriate acceptor molecules with a low-energy empty 
molecular orbital and thus explains the interaction between 
molecules by way of delocalized pairs of electrons. The 
energy of the LUMO (ELUMO) standardizes the electron-
accepting tendency of a molecule. Accordingly, ELUMO, 
EHOMO, the electronic charge on nitrogen and oxygen atoms, 
and the total energy of molecule (ET) were determined and 
compared. The global hardness (η) could also be estimated 
from the HOMO-LUMO gap because it is approximated as 
∆E/2,34 and can be defined under the principle of chemical 
hardness and softness.35 These parameters also provide 
information about the reactive behavior of molecules and 
are shown in Table 1.
Because exogenous ALA-mediated accumulation of 
PpIX occurs in the aqueous phase, it is necessary to include 
the effect of water in the computational calculations. In a 
similar way, it is important to take into account the effects 
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Figure 1 Synthesis procedures of ALA-p(His) by ring-opening polymerization of Bn-His-NCA, followed by deprotection: (A) PCl5, 1,4-dioxane; (B) N, N′-dimethylformamide; 
and (C) HBr/AcOH, TFA at 0°C.
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Figure 2 1H nuclear magnetic resonance spectra of ALA-p(His)15 in dimethyl-d6 sulfoxide at 25°C. 
Abbreviation: ALA, 5-aminolevulinic acid.
Table 1 Molecular properties of ALA and ALA-p(His)n molecules calculated using the density functional theory method in the 
aqueous phase
ALA ALA-p(His)5 ALA-p(His)10 ALA-p(His)15
Total energy (Ha) −476.018 −2834.929 −5158.953 −7502.025
Solvation energy (Ha) −0.030 −0.147 −0.190 −0.186
Surface area of cavity [Å2] 158.350 709.697 922.325 1209.550
Total volume of cavity [Å3] 147.286 840.290 1415.375 2035.672
LUMO (eV) −5.472 −4.959 −5.310 −5.163
HOMO (eV) −1.532 −1.876 −1.894 −2.257
∆E = (ELUMO − EHOMO) 3.940 3.083 3.416 2.906
η = ∆E/2 1.970 1.542 1.708 1.453
Abbreviations: ALA, 5-aminolevulinic acid; HOMO, highest occupied molecular orbital; LUMO, lowest occupied molecular orbital.
that can appear as much in the geometric properties as 
in the electrical ones. Dmol3 includes certain COSMO36 
  controls, which allows for solvation effects. The COSMO is 
a   continuum solvation model in which the solute molecule 
forms a cavity within the dielectric continuum of permittivity, 
and ε represents the solvent. The solvent molecules are mod-
eled as a continuous uniform dielectric constant (ε = 78.39 
for water) and the solute is placed in a cavity within it.34 The 
cavity surface (or solvent-accessible surface) is obtained as a 
superimposition of spheres centered at the atoms, discarding 
all parts lying on the interior part of the surface.24 The spheres 
are represented by a discrete set of points, ie, the so-called 
basic points. Eliminating the parts of the spheres that lie 
within the interior part of the molecule thus amounts to 
eliminating the basic grid points that lie in the interior of the 
molecule. The radii of the spheres are determined as the sum 
of the van der Waals radii of the atoms of the molecule and 
of the probe radius. The surviving basic grid points are then 
scaled to lie on the surface generated by the spheres of van 
der Waals radii alone. The basic points are then collected into 
segments, which are also represented as discrete points on 
the surface. The screening charges are located at the segment 
points. The results for the solvent-accessible surface, total and 
solvation energies, HOMO and LUMO orbital energies, ∆E, 
and η, calculated for ALA, ALA-p(His)5, ALA-p(His)10, and 
ALA-p(His)15 in the aqueous phase, are shown in Table 1. 
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The optimized geometries, including the cavity surface of 
the compounds as well as the HOMO and LUMO molecular 
orbitals, are shown in Figure 3.
As expected, the surface area and volume of the cavity 
increase as the size of the molecule increases from ALA to 
ALA-p(His)15. Global hardness is a parameter that gives 
important information about the reactive behavior of the 
molecule. The ALA molecule shows the maximum hardness 
value, and decreases in order of ALA-p(His)10 . ALA-
p(His)5 . ALA-p(His)15. The ALA molecule has the highest 
ALA
HOMO
LUMO
Fukui minus
Fukui plus
Structure and
accessible
surface locus
p(His)5−ALA p(His)10−ALA p(His)15−ALA
Figure 3 Geometry optimized structure of ALA and ALA-p(His)n, molecular orbital plots as well as Fukui active sites for electrophilic and nucleophilic attack on ALA and 
ALA-p(His)n molecules.
Note: The density functional theory and Fukui indices calculations were performed in the aqueous phase. 
Abbreviations: ALA, 5-aminolevulinic acid; HOMO, highest occupied molecular orbital; LUMO, lowest occupied molecular orbital.
EHOMO and lowest ELUMO, which explains the higher tendency 
of the molecule to donate electrons as well as accept 
electrons from neighboring water molecules. These values 
can change significantly by conjugating p(His) units to the 
ALA molecule. In addition, HOMO moves from the nitrogen 
atom of the ALA molecule to the nitrogen atoms of the his-
tidine rings in ALA-p(His)n molecules. This would indicate 
that the preferred active sites for electrophilic attack are 
located within the region around the nitrogen atoms belong-
ing to the histidine rings, before the p(His) units dissociate 
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from ALA-p(His) conjugates. These differences in ∆E and 
positions of HOMO and LUMO result in wide variations 
in solubility in water, especially in different pH conditions 
and with light-induced accumulation of PpIX. The solvation 
energy, ie, change in Gibbs energy when a molecule is trans-
ferred from a vacuum to a solvent, decreases sharply after 
p(His) units are conjugated to an ALA molecule. Considering 
that the main contributions to the solvation energy come 
from the cavitation energy of formation of the hole which 
preserves the dissolved species in the solvent, the orienta-
tion energy of partial orientation of the dipoles, the isotropic 
interaction energy of electrostatic and dispersion origin, and 
the anisotropic energy of specific interactions, eg, hydrogen 
bonds and donor-acceptor interactions, the ALA molecule is 
expected to show quite different behavior in water from the 
ALA-p(His) molecules.
Among the theoretical models proposed to compute 
local reactivity indices is the Fukui functions that make it 
possible to rationalize the reactivity of individual molecular 
orbital contributions, and thus to account for the response of 
the whole molecular spectrum, not just that of the frontier 
orbitals. Several benchmark applications of this protocol, 
describing selectivity and reactivity by means of orbital Fukui 
indices, have been presented by Mineva et al.37 With the pur-
pose of having a wider knowledge about the local reactivity 
of ALA and ALA-p(His) hybrids, Fukui indices for each one 
of the atoms in the molecules have been calculated. Analysis 
of the Fukui indices, along with the distribution of charges 
and global hardness, provides a more complete scheme 
of the reactivity of the studied molecules.38 Fukui indices 
calculated for all the neutral atoms of ALA and each of the 
three ALA-p(His) hybrids are shown in Figure 2. It has been 
shown that local electron densities or charges are important 
in many chemical reactions and physicochemical proper-
ties of a compound.39 Frontier orbital electron densities on 
atoms provide a useful means for detailed characterization of 
donor-acceptor interactions. For finite systems such as ALA 
and ALA-p(His) hybrid molecules, when the molecule is 
accepting electrons, one has a Fukui plus charge (  fk
+), ie, the 
index for nucleophilic attack; when the molecule is donating 
electrons, one has a Fukui minus charge (  fk
−), ie, the index 
for electrophilic attack. An analysis of Fukui indices shows 
that, for ALA-His hybrid molecules, the nitrogen atoms in 
the histidine ring are more susceptible sites for electrophilic 
attack than those in the ALA units. The value of fk
+ was almost 
negligible for all the molecules, indicating insensitivity to 
nucleophilic attack.
Cytotoxicity and dark toxicity  
of prodrugs
To investigate the effect of ALA-p(L-His) as an alternative 
to ALA for PDT, HCT116 human colon cancer cells were 
used as a model cancer cell line. To confirm if the cell 
death effect was caused only by photoinduced cytotoxic-
ity, the cytotoxicity and dark toxicity of ALA and the 
synthesized ALA-p(L-His) derivatives were carried out 
at pH 7.4 and 6.8 in HEK293T and HCT116 cells in the 
absence of light. As shown in Figure 4, the viability of 
HEK293T and HCT116 cells in the presence of 1 mM ALA 
or the ALA-p(L-His) derivatives was relatively higher than 
100%; the prodrugs themselves did not affect cell survival. 
This result indicates that the effect of ALA and ALA-p(L-
His)-based PDT on HCT116 cells is dependent on the pro-
duction of PpIX from the prodrugs in the tumor cells, not 
on the prodrugs themselves. This clearly shows that ALA 
and ALA-p(L-His) derivatives promote cell proliferation, 
and do not affect cell survival in the absence of irradiation 
at concentrations below 1 mM.
Photodynamic therapy
The effect of ALA-p(L-His)-based PDT was evaluated by 
treating HCT116 cells with a concentration of 1 mM of 
the prodrug for 4 hours in the dark. After irradiation, the 
cell survival percentage, compared with control cells, was 
estimated using the MTT assay. From Figure 5, it is clear that 
ALA-p(L-His)n has high phototoxicity compared with ALA. 
Because the length of the histidine chain increases in the 
ALA-p(L-His)n prodrugs, the PDT effect was found to 
be more   powerful. In particular, high phototoxicity was 
observed when the cells were treated with ALA-p(L-His)15 
compared with treatment using ALA alone. In addition, 
phototoxicity was higher when the cells were incubated 
with ALA-p(L-His)10 and ALA-p(L-His)15 at lower pH 
than at the physiological pH of 7.4. The imidazole ring 
(pKb about 6.5) of p(L-His) has lone pairs of electrons 
that endow it with pH-dependent amphoteric properties. 
Protonation was seen to occur just below physiological pH, 
indicating that the histidine unit attached to the ALA-p(L-
His)n prodrugs can act as a proton receptor and consequently 
effect internalization into the tumor cells. Both charged and 
uncharged forms of histidine are present in p(His) at neutral 
pH, and the concentration ratio of the charged form to the 
uncharged form is very sensitive to small changes in pH 
under physiological conditions.40 Moreover, the ionization 
of p(L-His) switches the nature of the material to becoming 
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more lipophilic, and p(L-His) shows strong endosomolytic 
properties by its proton sponge effect and/or its interaction 
with anionic phospholipids comprising the endosomal 
compartments.22
The low pH value in the interstitial fluid in most tumors 
certainly plays a significant role, because many of the tumor-
localizing photosensitizers are protonated, become more 
lipophilic, and accumulate faster in cells upon lowering the 
pH of the incubation medium. Application of ALA or ALA-
p(L-His)n leads to accumulation of the PpIX photosensitizer 
in tumors. Low levels of ferrochelatase activity and high lev-
els of porphobilinogen deaminase activity have been found 
in malignant cells and tissues,41–43 which may contribute to 
the observed tumor selectivity of PpIX.44,45
As described above, the endocytosis rate of ALA-
p(L-His) derivatives in tumor cells initially increases in acidic 
pH, and it is expected that the differences in phototoxicity 
under different pH conditions is due to the proton sponge 
effect of the p(L-His) residues and is a consequence of the 
pH dependency of porphobilinogen deaminase in malignant 
cells and tissues. This phenomenon was clearly observed for 
all the prodrugs, and was stronger with increasing lengths 
of the histidine tag.
PpIX production by ALA  
and p(L-His)-ALA
PpIX accumulation in HCT116 cells, induced by a 4-hour 
treatment with 1 mM each of ALA and ALA-p(L-His)15, was 
observed by fluorescence microscopy. As shown in Figure 6, 
red fluorescence was observed in cells treated with ALA-p(L-
His)n prodrugs, whereas a slight or no fluorescence signal 
were observed in the ALA-treated and control groups, respec-
tively. These results indicate that the administered prodrugs 
were successfully converted to PpIX in HCT116 cells. We 
found that p(L-His) itself has fluorescence to some degree, 
therefore it is difficult to know the exact amount of intracel-
lular PpIX in the exit (data not shown). However, comparing 
the fluorescence image like dark toxicity and phototoxicity, 
it is clear that the synthesized ALA-p(L-His)n prodrugs do 
not have any cytotoxicity or dark toxicity in either normal 
cells or cancer cell lines. Therefore, the death phenomenon in 
cancer cells was only observed after irradiation at 1.0 J/cm2 
of light. Moreover, from the fluorescence images, we found 
that the fluorescence intensity became stronger at lower 
pH conditions with ALA-p(L-His)n prodrugs. This result 
is correlated with phototoxicity data from the synthesized 
prodrugs, ie, cell survival is lower in physiological condition 
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Figure 4 (A) Cytotoxicity of ALA and ALA-p(L-His) prodrugs in HEK293T cells. After 24 hours of starvation, the cells were treated with 0.1–1.0 mM of each ALA prodrug 
for 4 hours. Cell viability was determined by the MTT assay. (B) Cellular dark toxicity of ALA and ALA-p(L-His) prodrugs at 1 mM concentration in HCT116 cells at 
pH 6.8 and 7.4. After cultivation in a 96-well plate, the cells were treated with 1.0 mM of each ALA prodrug for 4 hours. Cell viability was determined by the MTT assay.
Abbreviations: ALA, 5-aminolevulinic acid; p(L-His), poly(L-histidine).
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Figure 5 The photodynamic effect of ALA and ALA-p(L-His) prodrugs (1 mM concentration) on HCT116 cells at pH 7.4 and 6.8. 100 µL of serum-free medium containing 
1.0 mM prodrugs was added to HCT116 cells following incubation for 4 hours.
Notes: The control was treated with serum-free medium in the absence of both ALA and p(L-His)-ALA. After irradiation at a dose of 1.0 J/cm2, the medium was removed 
and washed with phosphate-buffered saline. Next, a fresh 100 µL of RPMI with 10% phosphate-buffered saline was added and the cells were incubated for a further 24 hours. 
Cell phototoxicity was determined by MTT assay. 
Abbreviations: ALA, 5-aminolevulinic acid; p(L-His), poly(L-histidine).
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Figure 6 Fluorescence microscopic images of protoporphyrin IX accumulation from ALA and ALA-poly(L-histidine) prodrugs in HCT116 cells at pH 7.4 (A–D) and at pH 6.8 
(A1–A4). HCT116 cells were treated with 1.0 mM ALA or poly(L-histidine)-ALA for 4 hours in serum-free media.
Note: The cells were fixed by 4% paraformaldehyde in phosphate-buffered saline and the cells were observed using a fluorescence microscope. 
Abbreviation: ALA, 5-aminolevulinic acid.
in lower pH condition. The fluorescence images of cells 
treated with ALA-p(L-His)n prodrugs or ALA for 4 hours 
showed that ALA-p(L-His)n prodrugs are potentially strong 
photosensitizers, dependent on the environmental conditions 
of the culture, ie, pH 6.8 or pH 7.4.
Necrosis induced by ALA  
or p(L-His)-ALA PDT
After ALA or ALA-p(L-His)n-based PDT, tumor cells 
were stained with FITC-annexin V and propidium iodide 
to visualize apoptotic cells (Figure 7A) and necrotic cells 
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(Figure 7B), respectively. As shown in Figure 7, the   number 
of apoptotic cells gradually increased in acidic pH and 
with ALA-p(L-His)15. Furthermore, the number of necrotic 
cells also dramatically increased according to the culture 
environment or prodrug, and necrosis of the tumor cells was 
dominant over apoptosis.
The proportion of apoptotic cells was estimated to 
be about 5.1% when they were treated with ALA alone. 
The same phenomenon was observed in the necrotic cells 
(approximately 13%). The proportions of apoptotic and 
necrotic cells in the ALA-treated groups show similar 
populations regardless of culture pH. In ALA-based PDT, 
phototoxicity was induced by apoptosis or necrosis and envi-
ronmental pH did not affect the cell death signals. A distinct 
phenomenon was observed in the newly synthesized prodrug-
treated groups. The proportion of apoptotic and necrotic cells 
increased from 12% to 19% and 38% to 45%, respectively, 
when treated with ALA-p(L-His)15 at pH 6.8. These results 
indicate that PDT based on both ALA and ALA-p(L-His)n 
induced death of HCT116 cells via apoptosis and necrosis, 
and, furthermore, that pH-sensitive cell death was induced 
during ALA-p(L-His)n-based PDT.
Conclusion
We propose a new system with an easy synthetic approach 
involving the use of p(His) tags on ALA to improve PDT 
selectivity in the treatment of cancer. P(His)-based ALA 
prodrugs did not show any cytotoxicity when administered to 
HCT116 cells for 4 hours. The prodrug showed phototoxicity 
even if administered for a short time (4 hours), and this 
phenomenon was significantly higher in the ALA-p(L-His)15-
treated group than in the control group. It is believed that 
the increased phototoxicity of these prodrugs at different pH 
conditions is due to the proton sponge effect of the p(L-His) 
residues and is a consequence of the high activity of porpho-
bilinogen deaminase in malignant cells and tissues under 
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Figure 7 Apoptosis and necrosis induced by ALA or ALA-p(L-His)15 photodynamic therapy in HCT116 cells at pH 7.4 and 6.8. After prodrugs or nontreatment for 4 hours, 
HCT cells were illuminated at 635 nm. Cells were stained with FITC-annexin V (A) and propidium iodide (B), then analyzed using a flow cytometer.
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Abbreviations: ALA, 5-aminolevulinic acid; p(L-His), poly(L-histidine).
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the pH conditions found in culture. The newly synthesized 
ALA-p(L-His)n derivatives are considered to be an effective 
alternative to ALA for enhancing PpIX production and the 
selectivity of the phototoxic effect in tumor cells.
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Novel poly(L-histidine) tagged 5-aminolevulinic acid   prodrugs: new photosensitizing   precursors of protoporphyrin IX for 
photodynamic therapy for colon cancer.
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Figure S1 13C nuclear magnetic resonance spectra of ALA-p(His)15 in dimethyl-d6 sulfoxide at 25°C. 
Abbreviation: ALA, 5-aminolevulinic acid.
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Figure S2 Gel permeation chromatography traces of (A) ALA-p(His)5, (B) ALA-p(His)10, and (C) ALA-p(His)15.
Note: Increment of molecular weight and monodispersity are clearly visible. 
Abbreviation: ALA, 5-aminolevulinic acid.
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Figure S3 Ultraviolet-visible spectra of ALA (λmax 267 nm) and ALA-p(His) derivatives show two absorption maxima (λmax 267 nm and 336 nm). 
Abbreviation: ALA, 5-aminolevulinic acid.
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Figure S4 Fourier transform infrared spectra of ALA-p(His) derivatives shows characteristic bond stretching. 
Abbreviation: ALA, 5-aminolevulinic acid.
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